Hexarelin peptide, a synthetic hexapeptide, is primarily recognized for its capacity to stimulate the release of growth hormone (GH). It’s structurally similar to growth hormone-releasing peptides (GHRPs), which include GHRP-2 and GHRP-6.
Hexarelin functions by binding to the ghrelin/growth hormone secretagogue receptor (GHSR) located in the pituitary and hypothalamic region. This binding triggers an increase in intracellular calcium levels, leading to the stimulation of growth hormone release. Finland Studies have shown that Hexarelin exhibits a more potent GH-releasing effect compared to other GHRPs, positioning it as a promising candidate for further exploration in the realm of endocrinology.
Showing all 5 results
SALE
[1] https://pubmed.ncbi.nlm.nih.gov/10342360/
[2] https://pubmed.ncbi.nlm.nih.gov/10512687/
[3] https://pubmed.ncbi.nlm.nih.gov/34856183/
[4] https://pubmed.ncbi.nlm.nih.gov/14615277/
[5] https://pubmed.ncbi.nlm.nih.gov/10974647/
[6] https://pubmed.ncbi.nlm.nih.gov/8762732/
[7] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC5638899/
[8] https://pubmed.ncbi.nlm.nih.gov/25645463/
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Peptides website: https://finland.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
401 N. Mills Ave, Ste B, Orlando, FL 32803, United States